Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:45 PM
Ignite Modification Date:
2025-12-24 @ 9:45 PM
NCT ID:
NCT02485132
Eligibility Criteria:
Inclusion Criteria:
* Type 2 diabetes according to Canadian Diabetes Association definition
* Initiation of a SU at baseline
* A1c: 7.0% to 10.0%
* Willing and able to comply with study procedures
Exclusion Criteria:
* Current or previous usage (during the last 3 months) of insulin or repaglinide
* Use of medication known to interfere with glucose metabolism
* Insulin requiring patient: catabolic state and/or ketonuria
* Currently using CGMS or within the last 3 months
* Recent severe hypoglycemia (\<3 months)
* Pregnancy or breast-feeding
* Limited life expectancy, high level of functional dependency, extensive coronary disease at high risk of short term ischemic events or multiple major co-morbidities
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02485132
Study Brief:
Protocol Section:
NCT02485132